Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EEG response to scopolamine in AD, MCI and controls
NCT02273895Completed
- Sponsor
- Mentis Cura
- Start
- Apr 2004
- Primary completion
- Oct 2004
01
Overview
Open-label trial (3 arms), sponsored by Mentis Cura. Primary endpoint: Changes in EEG as a result of scopolamine administration at 1 hour. Started Apr 2004; status: completed.
Beyond the preview
Go deeper on NCT02273895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02273895.